Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972162priorityCriticalpatent/ECSP972162A/en
Publication of ECSP972162ApublicationCriticalpatent/ECSP972162A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente se relaciona con formas sólidas de dosificación oral que comprende: a) un agente activo seleccionado de valsartan y opcionalmente HCTZ, y b) aditivos farmacéuticamente aceptables adecuados para la preparación de formas sólidas de dosificación oral por métodos de compresión.The present invention relates to solid oral dosage forms comprising: a) an active agent selected from valsartan and optionally HCTZ, and b) pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
ECSP9721621997-06-251997-06-25
SOLID ORAL DOSAGE FORMS CONTAINING VALSARTAN
ECSP972162A
(en)
ADMINISTRABLE GALENIC FORMULATION BY ORAL ROUTE THAT ALLOWS AN IMPROVED ABSORPTION OF ACTIVE PRINCIPLES, USE OF AN ABSORPTION MAJORATING AGENT TO PREPARE AN ADMINISTRABLE DOSAGE METHOD BY ORAL ROUTE AND PROCEDURE TO PREPARE THE GINAL FORMULA
Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended.